FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103673693> ?p ?o ?g. }

• W2103673693 endingPage "312" @default.
• W2103673693 startingPage "305" @default.
• W2103673693 abstract "Several studies have shown symptomatic and haemodynamic improvement after the introduction of angiotensin converting enzyme inhibitors in patients with heart failure treated with diuretics. The concomitant long term effects of the new orally effective long acting angiotensin converting enzyme inhibitor, enalapril, on symptoms, exercise performance, cardiac function, arrhythmias, hormones, electrolytes, body composition, and renal function have been further assessed in a placebo controlled double blind cross over trial with treatment periods of eight weeks. Twenty patients with New York Heart Association functional class II to IV heart failure who were clinically stable on digoxin and diuretic therapy were studied. Apart from the introduction of enalapril, regular treatment was not changed over the study period; no order or period effects were noted. Enalapril treatment significantly improved functional class, symptom score for breathlessness, and exercise tolerance. Systolic blood pressure was significantly lower on enalapril treatment. Echocardiographic assessment indicated a reduction in left ventricular dimensions and an improvement in systolic time intervals. In response to enalapril, the plasma concentration of angiotensin II was reduced and that of active renin rose; plasma concentrations of aldosterone, vasopressin, and noradrenaline fell. There were significant increases in serum potassium and serum magnesium on enalapril. Glomerular filtration rate measured both by isotopic techniques and by creatinine clearance declined on enalapril while serum urea and creatinine rose and effective renal plasma flow increased. Body weight and total body sodium were unchanged indicating that there was no overall diuresis. There was a statistically insignificant rise in total body potassium, though the increase was related directly to pretreatment plasma renin (r = 0.5). On enalapril the improvement in symptoms, exercise performance, fall in plasma noradrenaline, and rise in serum potassium coincided with a decline in the frequency of ventricular extrasystoles recorded during ambulatory monitoring. Adverse effects were few. In patients with heart failure, enalapril had a beneficial effect on symptoms and functional capacity. The decline in glomerular filtration rate on enalapril may not be beneficial in early heart failure." @default.
• W2103673693 created "2016-06-24" @default.
• W2103673693 creator A5001539589 @default.
• W2103673693 creator A5016095791 @default.
• W2103673693 creator A5042148457 @default.
• W2103673693 creator A5045982685 @default.
• W2103673693 creator A5049723954 @default.
• W2103673693 creator A5050158125 @default.
• W2103673693 creator A5073138706 @default.
• W2103673693 creator A5074396459 @default.
• W2103673693 creator A5079713265 @default.
• W2103673693 creator A5083796929 @default.
• W2103673693 date "1985-09-01" @default.
• W2103673693 modified "2023-10-04" @default.
• W2103673693 title "Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state." @default.
• W2103673693 cites W125318081 @default.
• W2103673693 cites W1463717739 @default.
• W2103673693 cites W1495193922 @default.
• W2103673693 cites W1967896949 @default.
• W2103673693 cites W1971680322 @default.
• W2103673693 cites W1974235653 @default.
• W2103673693 cites W1976346162 @default.
• W2103673693 cites W1977173164 @default.
• W2103673693 cites W1980998139 @default.
• W2103673693 cites W1982347549 @default.
• W2103673693 cites W1984656428 @default.
• W2103673693 cites W1990919233 @default.
• W2103673693 cites W2000911265 @default.
• W2103673693 cites W2004105502 @default.
• W2103673693 cites W2009554350 @default.
• W2103673693 cites W2011461059 @default.
• W2103673693 cites W2011526237 @default.
• W2103673693 cites W2015063938 @default.
• W2103673693 cites W2023214403 @default.
• W2103673693 cites W2039120849 @default.
• W2103673693 cites W2047026126 @default.
• W2103673693 cites W2048422635 @default.
• W2103673693 cites W2051165221 @default.
• W2103673693 cites W2064113230 @default.
• W2103673693 cites W2068033616 @default.
• W2103673693 cites W2073248609 @default.
• W2103673693 cites W2074588774 @default.
• W2103673693 cites W2078194622 @default.
• W2103673693 cites W2081884590 @default.
• W2103673693 cites W2083945596 @default.
• W2103673693 cites W2095038529 @default.
• W2103673693 cites W2096073058 @default.
• W2103673693 cites W2119380023 @default.
• W2103673693 cites W2120525089 @default.
• W2103673693 cites W2120641380 @default.
• W2103673693 cites W2131473550 @default.
• W2103673693 cites W2135603039 @default.
• W2103673693 cites W2146421101 @default.
• W2103673693 cites W2159096663 @default.
• W2103673693 cites W2166168086 @default.
• W2103673693 cites W2279511258 @default.
• W2103673693 cites W2305919962 @default.
• W2103673693 cites W2312342505 @default.
• W2103673693 cites W2331058240 @default.
• W2103673693 cites W2365268540 @default.
• W2103673693 cites W2413695779 @default.
• W2103673693 cites W2416793131 @default.
• W2103673693 cites W2468380692 @default.
• W2103673693 cites W3212439637 @default.
• W2103673693 cites W4210336424 @default.
• W2103673693 cites W4320300920 @default.
• W2103673693 cites W88743738 @default.
• W2103673693 doi "https://doi.org/10.1136/hrt.54.3.305" @default.
• W2103673693 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/481900" @default.
• W2103673693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2994698" @default.
• W2103673693 hasPublicationYear "1985" @default.
• W2103673693 type Work @default.
• W2103673693 sameAs 2103673693 @default.
• W2103673693 citedByCount "272" @default.
• W2103673693 countsByYear W21036736932012 @default.
• W2103673693 countsByYear W21036736932013 @default.
• W2103673693 countsByYear W21036736932015 @default.
• W2103673693 countsByYear W21036736932016 @default.
• W2103673693 countsByYear W21036736932017 @default.
• W2103673693 countsByYear W21036736932019 @default.
• W2103673693 countsByYear W21036736932020 @default.
• W2103673693 countsByYear W21036736932021 @default.
• W2103673693 countsByYear W21036736932022 @default.
• W2103673693 countsByYear W21036736932023 @default.
• W2103673693 crossrefType "journal-article" @default.
• W2103673693 hasAuthorship W2103673693A5001539589 @default.
• W2103673693 hasAuthorship W2103673693A5016095791 @default.
• W2103673693 hasAuthorship W2103673693A5042148457 @default.
• W2103673693 hasAuthorship W2103673693A5045982685 @default.
• W2103673693 hasAuthorship W2103673693A5049723954 @default.
• W2103673693 hasAuthorship W2103673693A5050158125 @default.
• W2103673693 hasAuthorship W2103673693A5073138706 @default.
• W2103673693 hasAuthorship W2103673693A5074396459 @default.
• W2103673693 hasAuthorship W2103673693A5079713265 @default.
• W2103673693 hasAuthorship W2103673693A5083796929 @default.
• W2103673693 hasBestOaLocation W21036736932 @default.
• W2103673693 hasConcept C126322002 @default.
• W2103673693 hasConcept C134018914 @default.

• next